Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis

Fig. 1

Kaplan-Meier plots of local control (LC), distant intracranial control (DIC) and overall survival (OS) for all patients with melanoma brain metastases treated with stereotactic radiosurgery (SRS). One- and 2-year LC rates after SRS were 98.1 and 95.4%, respectively (a). One- and 2-year DIC rates after SRS were 54.2 and 36.6%, respectively, median 16 months (b). Median overall survival was 22 months after first diagnosis of brain metastasis. One– and 2-year OS rates were 66.3 and 48.6% after first diagnosis of brain metastasis (c)

Back to article page